Biolife solutions to present at td cowen and key bank investor conferences

Bothell, wash. , march 4, 2024 /prnewswire/ -- biolife solutions, inc. (nasdaq: blfs), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("cgt") and broader biopharma markets, today announced that roderick de greef, chief executive officer, and troy wichterman, chief financial officer, will present and meet with current and prospective investors at the following march investor conferences.
BLFS Ratings Summary
BLFS Quant Ranking